Detalhe da pesquisa
1.
Patient-centered assessment of cognitive symptoms of depression.
CNS Spectr
; 21(1): 43-52, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24067243
2.
Cost-effectiveness of abobotulinumtoxinA plus best supportive care compared with best supportive care alone for early treatment of adult lower limb spasticity following an acute event.
PLoS One
; 19(2): e0296340, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38300954
3.
Health care resource utilization and costs among patients with spasticity or cervical dystonia.
J Manag Care Spec Pharm
; 30(1): 86-97, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38055046
4.
Efficacy of abobotulinumtoxinA versus onabotulinumtoxinA for the treatment of refractory neurogenic detrusor overactivity: a systematic review and indirect treatment comparison.
J Med Econ
; 26(1): 200-207, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36647624
5.
A UK Single-Center, Retrospective, Noninterventional Study of Clinical Outcomes and Costs of Two BotulinumtoxinA Treatments for Limb Spasticity.
Toxins (Basel)
; 15(9)2023 08 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37755958
6.
Cost-effectiveness evaluation in Sweden of escitalopram compared with venlafaxine extended-release as first-line treatment in major depressive disorder.
Value Health
; 15(2): 231-9, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22433753
7.
The use and performance of productivity scales to evaluate presenteeism in mood disorders.
Value Health
; 15(8): 1148-61, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23244819
8.
The cost-effectiveness of abobotulinumtoxinA (Dysport) and onabotulinumtoxinA (Botox) for managing spasticity of the upper and lower limbs, and cervical dystonia.
J Med Econ
; 25(1): 919-929, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35730362
9.
Modelling Long-Term Outcomes and Risk of Death for Patients with Post-Stroke Spasticity Receiving Abobotulinumtoxina Treatment and Rehabilitation Therapy.
J Rehabil Med
; 54: jrm00303, 2022 Aug 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-35844200
10.
Erythrocyte C3d and C4d for monitoring disease activity in systemic lupus erythematosus.
Arthritis Rheum
; 62(3): 837-44, 2010 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-20187154
11.
Cost-effectiveness of vortioxetine compared with levomilnacipran and vilazodone in patients with major depressive disorder switching from an initial antidepressant.
Expert Rev Pharmacoecon Outcomes Res
; 21(1): 29-42, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33307885
12.
Cost effectiveness and impact on quality of life of abobotulinumtoxinA and onabotulinumtoxinA in the treatment of children with lower limb spasticity in Canada.
J Med Econ
; 23(6): 631-640, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31985313
13.
Association between depression and coronary artery calcification in women with systemic lupus erythematosus.
Rheumatology (Oxford)
; 48(5): 576-81, 2009 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-19286698
14.
Botulinum Toxins Type A (Bont-A) in the Management of Lower Limb Spasticity in Children: A Systematic Literature Review and Bayesian Network Meta-analysis.
J Child Neurol
; 34(7): 371-381, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30803305
15.
C-reactive protein and coronary artery calcium in asymptomatic women with systemic lupus erythematosus or rheumatoid arthritis.
Am J Cardiol
; 102(6): 755-60, 2008 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18774002
16.
Escitalopram and duloxetine in major depressive disorder: a pharmacoeconomic comparison using UK cost data.
Pharmacoeconomics
; 26(11): 969-81, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18850765
17.
Psychometric validation of the Perceived Deficits Questionnaire-Depression (PDQ-D) instrument in US and UK respondents with major depressive disorder.
Neuropsychiatr Dis Treat
; 14: 2861-2877, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30464471
18.
The burden of illness associated with renal cell carcinoma in the United States.
Urol Oncol
; 25(5): 368-75, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-17826652
19.
The impact of antidepressant treatments on family functioning in adults with major depressive disorder: a post hoc comparison of vortioxetine and agomelatine.
Curr Med Res Opin
; 33(6): 1057-1066, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28277865
20.
Comparative evaluation of vortioxetine as a switch therapy in patients with major depressive disorder.
Eur Neuropsychopharmacol
; 27(8): 773-781, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28663124